Sales Manager

PROFESSIONAL STATEMENT: To secure a senior-level Business Development, Strategic Marketing & Sales leadership position within a growth-oriented company who aspires to differentiate their brand and challenge the status-quo.

DIVERSE EXPERTISE:

Start-up Ventures: Vidara Therapeutics Inc. EKR Therapeutics Inc. Vertex Partners LLC

Diverse Industry Expertise: Life Sciences Enterprise Health Medical Private Equity Consulting Firms

Launch Experience: Launched 12 products and 5 service platforms

EDUCATION:

St. John Fisher College; Rochester, NY: B.A. Communications, 2003

NCAA Football, 4-year starter at Wide Receiver NFL Free-agent Tryouts (National Football League)

Professional Experience

ELI GLOBAL, LLC: AUGUST 2015 – PRESENT (CONTRACT)

VICE PRESIDENT, BUSINESS DEVELOPMENT HEALTHCARE ENTERPRISE SOLUTIONS: Executive Marketing and Sales leader of two business units across Revenue Cycle Management, Electronic Health Records, Clinical Analytics, Market Insights and Consulting:

oRecruited as Vice President of CBS Group Services, a Revenue Cycle & Electronic Health Records for hospitals and providers

oExecutive leader of Canta Health, Market Insights and Clinical Support software for Pharmaceutical/Medical industries

oAccountable for exceeding the 5 year forecasts of $100 million revenues & 20% EBITA for the RCM division

oDrove $5 million gross revenues within the first 3 months of our go-to-market launch, Q1 2016

oBuilt the national sales model and created all components of Marketing, Sales Training, Sales Operations

oStructured strategic partnerships with MDoffice for EMR offerings, and ManagementPlus for a national webinar series

oElected to Eli’s Merger & Acquisition Committee to assess portfolio expansion opportunities & deal-flow

VERTEX PARTNERS, LLC: FEBRUARY 2014 – AUGUST 2015

VICE PRESIDENT, COMMERCIAL STRATEGY LIFE SCIENCE CONSULTING: Drove revenues of consulting products/services comprised of Business Development Strategy, Sales Training Programs, Product Management and Interim Leadership projects:

oScope of Clientele: Start-Ups Early Stage Companies Private Equity Consulting Firms

oIndustries Served: Biotech Pharmaceuticals Enterprise Health Technology Medical Device Clinical Research/Regulatory

oManaged P&L of $50 million, 20% EBITA and expanded contract margins by $408,000

oGrew year-over-over total revenues 38% by adding 15 new clients yielding $2.5 million

oExpanded sales teams from 7 to 20 personnel and promoted 5 sales members to Sr. Key Account Managers

VIDARA THERAPEUTICS INC.: JULY 2012 – FEBRUARY 2014 (acquired by Horizon) Atlanta, GA

MANAGER, MARKETING & BUSINESS DEVELOPMENT BIOTECH ORPHAN DISEASE SECTOR: One of Vidara’s original commercial members. Led strategic initiatives across Brand Management, Training, Sales, Acquisitions and Global Sales Operations:

oProduct: Actimmune® (Interferon Gamma)

oMarkets: Orphan Diseases Oncology Stem Cell Transplant Immunology Infectious Disease

oKey Accounts: Duke Clinical Research Institute Emory Winship Cancer Vanderbilt St. Jude Children’s UNC

oClosed $2.75 million in new business and managed $4 million P&L across sales & marketing activities

oDrove sales revenues to $80 million and 30% EBITA until the company’s acquisition for $660 million, 2012-2014

oCOMPASSSM: Built the Specialty Pharmacy HUB and secured reimbursement services available through COMPASS

oCreated Vidara’s Sales Training platform, Marketing Brand Guidelines and formed the Promotional Review Committee

oActimmune.com: Launched the company’s first-ever product website, SEO, PPC, Content Marketing & PR campaigns

oCompassforpatients.com: Launched the unbranded patient engagement website as a disease-state awareness platform

AMGEN INC.: OCTOBER 2011 – JULY 2012 Orlando, FL

MANAGER, KEY ACCOUNTS IMMUNO-ONCOLOGY MARKET: Re-structured product sales of Prolia®, then promoted to a Key Account Manager for Enbrel® for broadening market access and product revenues:

oProducts: Prolia® (monoclonal antibody); Enbrel® (TNF inhibitor)

oTargets: Oncology OBGYN Genetics Infusion Centers Injection Networks Hospitals

o#6 of 460; 2011-2012 National Ranking

o207% sales quota attainment, 2011-2012; grew territory performance to 6th of 460 from 447th of 460

oMarket Access: Buy & Bill Medicare Part B J-Codes CPT Codes Specialty Pharmacy HUB

EKR THERAPEUTICS INC.: MARCH 2009 – OCTOBER 2011 (acquired by Cornerstone) Orlando, FL

NATIONAL SALES TRAINER & EXECUTIVE HOSPITAL MANAGER MEDICAL DEVICE: Recruited to implement the regional strategy for augmenting contract revenue of product sales:

oProducts: Cardene® I.V. RetaVase® DepoDur® (Intravenous & Injectable Biologic Therapies)

oTargets: Surgical Oncology ICU, CVICU Stroke Centers Neuro-Critical Care Cardiac Surgery Anesthesia

oNational Rankings: #3 of 43 (2011) #9 of 45 (2010) #13 of 45 (2009)

o120% year-over-year quota attainment resulting in $2.5 million in annual sales, 2009-2011

oGrew Florida Hospital as EKR’s #1 national account generating $350,000 per quarter

oSecured 1st-line use on hospital treatment protocols and Point-of-Care dispensing of Cardene® I.V.

oC-suite Customers: HCA, VHA, Adventist, Mayo Clinic, Orlando Health, Florida Hospital

ALPHARMA INC.: AUGUST 2006 – MARCH 2009 (acquired by Pfizer) San Diego, CA

ASSOCIATE MANAGER, SALES TRAINING – WEST COAST REGION: Regional zone leader for all facets of sales training, including platform design, field coaching, e-learning, centers of excellence, classroom facilitation and product messaging:

oProducts: Kadian® (morphine); Flector® (diclofinac)

oTargets: Oncology Anesthesia Neurology Orthopedics Surgeons

oNational Ranking: Top 20%, 2006-2008

o#1 of 6; Rookie of the Year, 2006

o#1 of 70; Representative of the Trimester, 2007

oDirect & Indirect Reports: Directly managed 7 Field Trainers; In-directly led 10 Managers and 90 Sales Reps

Contact this candidate